GLP-1 receptor agonists may help mitigate progression of at least some obesity-related cancers, according to retrospective ...

Treating breast cancer that has begun to spread around the body with targeted radiotherapy could help patients to live longer ...

Accumulating evidence of possible benefit warrants randomized trials, experts say ...

Sydney Towle shared a heartbreaking bile duct cancer update while raising awareness about cholangiocarcinoma symptoms, ...

Moderna and Merck's combination therapy for skin cancer helped reduce risk of cancer spreading to another part of the body ...

The popular children's entertainer shared the news on Instagram alongside a picture of his son and a black-and-white photo of ...

Detailed data from 55 patients to be shared in an oral presentation at the ASCO Annual Meeting on June 1, 2026 - - Tolerability profile consistent with prior updates: only two categories of Grade 3 or ...

Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion, recommending ...

TEM is integrating externally developed AI pathology into its ecosystem to improve risk prediction and personalize prostate ...

GLP-1 drugs, such as Ozempic and Wegovy, may slow down the spread of obesity-related cancers, according to researchers ...

Phase III Tropion‑Breast02 demonstrated a 43% reduction in progression/death risk versus chemotherapy, with median overall survival improved by five months in first-line metastatic TNBC. Objective ...

Treating breast cancer that has begun to spread around the body with targeted radiotherapy could help patients to live longer ...